VolitionRx Limited (VNRX) Stock

Healthcare · Medical Devices · Member of Other US Stocks

VolitionRx Limited (VNRX) closed at USD 0.18 on 2026-10-14, a change of -97.9 % over the past year, with a market capitalization of USD 5.67M.

VolitionRx Limited recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

VolitionRx Limited key figures

Previous close

USD 0.18 (2026-10-14)

1-year change

-97.9 %

Market cap

USD 5.67M

Enterprise value

USD 9.82M

P/E ratio (trailing)

-0.05

P/E ratio (forward)

-0.22

EPS (trailing)

-3.80

EPS (forward)

-0.85

PEG ratio

n/a

Price to book

-0.07

Revenue growth

-2 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.37

Employees

57

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About VolitionRx Limited

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for VolitionRx Limited and compare it with other stocks.